SPAC Valuence Merger Corp. Files for $200M IPO
SPAC Valuence Merger Corp. Files for $200M IPO
By Stephen Nakrosis
作者：斯蒂芬·納克羅斯西斯
Blank-check company Valuence Merger Corp. I filed for a $200 million initial public offering on Wednesday.
空白支票公司Valuence Merger Corp. I 週三申請了2億美元的首次公開募股。
The company said it would concentrate on identifying a potential business combination partner "developing breakthrough technology in life sciences and/or advancing a platform for sustainable technology."
該公司表示，將集中精力尋找潛在的業務合併合作伙伴，“開發生命科學領域的突破性技術和/或推進可持續技術平台”。
It also said, "we will not pursue or consummate our initial business combination with any entity with its principal business operations in China, Hong Kong or Macau.
它還說：“我們不會與任何主要業務位於中國、香港或澳門的實體進行或完善我們的初始業務合併。
Valuence Merger Corp. I said its sponsor, Valuence Capital LLC, is affiliated with investment fund Valuence Partners LP.
Valuence Merger Corp. 我說其贊助商Valuence Capital LLC隸屬於投資基金Valuence Partners
The company said director nominee Dr. Joong Myung Cho is founder, chairman and chief executive of CrystalGenomics Inc., and Sung Yoon Woo, its CEO and director, is founder and CEO of Credian Partners Inc.
該公司表示，董事提名人趙重明博士是CrystalGenomics Inc. 的創始人、董事長兼首席執行官，其首席執行官兼董事成允是Credian Partners Inc.的創始人兼首席執行官。
Valuence Merger Corp. I said it applied to list its units on the Nasdaq Global Market under the symbol VMCAU.
Valuence Merger Corp. 我表示，它申請在納斯達克全球市場上市，股票代碼爲VMCAU。
SVB Leerink is listed as the offering's sole book-running manager and Baird is listed as lead manager.
SVB Leerink被列爲該發行的唯一賬面經理，貝爾德被列爲首席經理。
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
通過 stephen.nakrosis@wsj.com 寫信給斯蒂芬·納克羅斯西斯
譯文內容由第三人軟體翻譯。